Estimating the Positive Benefits of Schedule 3 Consumer Advertising

Project Member(s): Goodall, S., Street, D., Viney, R., Haas, M.

Funding or Partner Organisation: Australian Self Medication Industry

Start year: 2015

Summary: This project will develop a research program for the Australian Self Medication Industry Inc (ASMI) that explores the impact of Schedule 3 consumer advertising, including any potential benefits to consumers. This project involves the development, design and analysis of complex discrete choice models; and the collection of data through a number of web-based surveys. The major costs are in personnel, and the data collection through on-line recruitment and survey administration.

Publications:

Meshcheriakova, O, Goodall, S, Street, D & Viney, R 1970, 'Does the price premium for branded medicines reflect preferences? A case study from Australia', 11th Meeting of the International Academy of Health Preference Research, Auckland, New Zealand.

Goodall, S, Zhao, F, Street, D & Viney, R 1970, 'Estimating the Impact of Direct-to-Consumer Advertising of Pharmacy Only Medicine Using Discrete Choice Experiments', Value in Health, ISPOR 7th Asia-Pacific Conference, Elsevier BV, Singapore, pp. A855-A855.
View/Download from: Publisher's site

Keywords: pharmacist only medicine, discrete choice experiment

FOR Codes: Health Economics, Health Policy Economic Outcomes, Health Policy Evaluation, Health economics , Evaluation of health and support services not elsewhere classified

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.